BUY MBP PEMBROLIZUMAB KEYTRUDA 100MG INJ BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Pembrolizumab is an immunotherapy medicine used to treat several types of cancer, including melanoma, lung cancer, head and neck cancer, bladder cancer, kidney cancer, and some other cancers. Pembrolizumab may be used alone or in combination with other cancer treatments. If you have been prescribed pembrolizumab, it means your oncology team has chosen a treatment that works by helping your own immune system recognise and attack cancer cells.

Pembrolizumab works very differently from traditional chemotherapy. Pembrolizumab is a type of medicine called a monoclonal antibody and belongs to a group known as immune checkpoint inhibitors. Normally, the immune system has ?brakes? to prevent it from attacking normal cells. One of these brakes involves a pathway called PD-1. Some cancer cells use this pathway to hide from the immune system. Pembrolizumab blocks the PD-1 pathway, removing this brake and allowing immune cells to recognise and attack cancer cells more effectively.

Because pembrolizumab activates the immune system, it does not directly kill cancer cells. Instead, it helps your immune system do the work. This means pembrolizumab can have different side effects compared to chemotherapy, and some effects may appear later during treatment or even after treatment has stopped.

Pembrolizumab is given as an intravenous infusion into a vein. Pembrolizumab is administered in a hospital or infusion clinic by trained healthcare professionals. You will not take pembrolizumab at home. Pembrolizumab is usually given once every few weeks, depending on your treatment schedule. Each infusion typically takes about 30 minutes, and you will be monitored during and after the infusion.

Now let?s talk about what to expect while receiving pembrolizumab.

Pembrolizumab is generally well tolerated, but because it stimulates the immune system, it can cause immune-related side effects. These side effects occur when the immune system becomes overactive and starts to affect normal organs and tissues. Early recognition is very important, because immune-related side effects are usually manageable when treated promptly.

Fatigue is one of the most common side effects of pembrolizumab. This can range from mild tiredness to more noticeable fatigue. Pace your activities and rest when needed.

Skin-related effects are common with pembrolizumab. These may include rash, itching, or skin dryness. Mild skin symptoms are common, but severe rash, blistering, or peeling skin should be reported immediately.

Pembrolizumab can affect the digestive system. Diarrhoea or bowel inflammation can occur. Seek medical advice promptly if you develop persistent diarrhoea, abdominal pain, blood or mucus in stools, or black stools. Do not try to self-treat severe diarrhoea without advice.

Pembrolizumab can affect hormone-producing glands such as the thyroid, adrenal glands, or pituitary gland. This can lead to symptoms such as unusual tiredness, weight changes, feeling cold or hot, headaches, dizziness, mood changes, or changes in heart rate. Blood tests are done regularly to monitor hormone levels, but report any new or persistent symptoms.

Pembrolizumab can affect the lungs, causing inflammation called pneumonitis. Seek urgent medical attention if you develop new or worsening shortness of breath, cough, chest pain, or fever.

Pembrolizumab can affect the liver. Blood tests monitor this. Seek medical advice if you notice yellowing of the skin or eyes, dark urine, severe nausea, vomiting, or right-sided abdominal pain.

Pembrolizumab can affect the kidneys, leading to changes in urine output or swelling. Report reduced urine output, swelling of the legs or face, or unexplained weight gain.

Less commonly, pembrolizumab can affect the heart, nerves, muscles, or eyes. Report symptoms such as chest pain, palpitations, muscle weakness, numbness, tingling, vision changes, or severe headaches immediately.

Infusion-related reactions can occur during or shortly after pembrolizumab administration. Symptoms may include fever, chills, flushing, rash, shortness of breath, dizziness, or low blood pressure. Nurses monitor you closely during the infusion. Always report any unusual symptoms immediately.

Because pembrolizumab works by stimulating the immune system, some side effects can occur weeks or months after starting treatment, and occasionally even after treatment has ended. It is important to tell any healthcare provider you see that you are receiving or have received pembrolizumab.

Pembrolizumab should not be used during pregnancy, as it may harm an unborn baby. Effective contraception is required during pembrolizumab treatment and for the period advised after the last dose. Breastfeeding is not recommended during pembrolizumab therapy.

Do not start steroids or immune-suppressing medicines unless directed by your oncology team, as these can interfere with pembrolizumab?s effect. However, if immune-related side effects occur, your doctors may prescribe steroids to control inflammation. This is expected and does not mean pembrolizumab has failed.

If you feel unwell at any time during pembrolizumab treatment, do not wait for your next appointment. Early reporting of symptoms is essential for safe management.

As your pharmacist, my role is to help you understand how pembrolizumab works, what side effects to watch for, and when to seek medical attention. I do not administer pembrolizumab or change treatment decisions, but I support safe and informed use through education and counselling.

Pembrolizumab has helped many people by harnessing the immune system to fight cancer. Understanding how pembrolizumab works and recognising symptoms early helps ensure you receive the greatest benefit from pembrolizumab while minimising risks.